Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 39:1229-1235
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maekawa, N.
Right arrow Articles by Seishima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maekawa, N.
Right arrow Articles by Seishima, M.

EXPERIMENTAL STUDY

Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-{alpha}

Naoya Maekawa, BSc*, Hisayasu Wada, MD, PhD*,*, Tsugiyasu Kanda, MD, PhD{ddagger}, Tamikazu Niwa, BSc*, Yasuhiro Yamada, MD, PhD*, Kuniaki Saito, PhD*, Hisayoshi Fujiwara, MD, PhD{dagger}, Kenji Sekikawa, PhD§ and Mitsuru Seishima, MD, PhD*

* Department of Laboratory Medicine, Gifu University School of Medicine, Gifu, Japan
{dagger} Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan
{ddagger} Department of Laboratory Medicine, Gunma University School of Medicine, Maebashi, Japan
§ Department of Immunology, National Institute of Animal Health, Tsukuba, Japan

Manuscript received February 28, 2001; revised manuscript received January 2, 2002, accepted January 11, 2002.

* Reprint requests and correspondence: Dr. Hisayasu Wada, Department of Laboratory Medicine, Gifu University School of Medicine, 40 Tsukasa-machi, Gifu City, Gifu 500-8705, Japan.
wadah{at}cc.gifu-u.ac.jp

OBJECTIVES: This study sought to assess the role of tumor necrosis factor-{alpha} (TNF-{alpha}) in myocardial ischemia/reperfusion (I/R) injury using TNF-{alpha} knockout (KO) mice.

BACKGROUND: Tumor necrosis factor-{alpha} is thought to be involved in the pathogenesis of myocardial I/R injury by promoting leukocyte infiltration of the myocardium. However, the precise role of TNF-{alpha} in I/R injury is still unknown.

METHODS: The hearts in TNF-{alpha} KO and wild-type (WT) mice were exposed by left lateral thoracotomy, and the left coronary artery was occluded for 30 min then reperfused for 120 min.

RESULTS: The infarct size in TNF-{alpha} KO mice was significantly reduced compared with WT mice. The frequency of arrhythmia was decreased, and cardiac function during reperfusion was significantly improved in TNF-{alpha} KO mice compared with WT mice. The activation of nuclear factor-{kappa}B (NF-{kappa}B), the expression of chemokines and adhesion molecules and the infiltration of leukocytes were also significantly reduced in TNF-{alpha} KO mice, compared with WT mice. These findings provide evidence that TNF-{alpha} aggravates I/R injury.

CONCLUSIONS: Tumor necrosis factor-{alpha} exacerbates myocardial I/R injury at an early stage of reperfusion by activating NF-{kappa}B, thereby inducing chemokines and adhesion molecules and facilitating leukocyte infiltration.

Abbreviations and Acronyms
  AAR
  area at risk
  IA
  infarct area
  ICAM
  intercellular adhesion molecule
  IL
  interleukin
  I/R
  ischemia/reperfusion
  KO
  knockout
  LV
  left ventricle
  MCP
  monocyte chemoattractant protein
  MIP
  macrophage inflammatory protein
  NF-{kappa}B
  nuclear factor-{kappa}B
  RT-PCR
  reverse transcription and polymerase chain reaction
  TNF-{alpha}
  tumor necrosis factor-{alpha}
  WT
  wild-type




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
L. Lacerda, S. Somers, L. H. Opie, and S. Lecour
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Cardiovasc Res, November 1, 2009; 84(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. L. Stables and M. J. Curtis
Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation
Cardiovasc Res, July 15, 2009; 83(2): 397 - 404.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Schulz and G. Heusch
Tumor Necrosis Factor-{alpha} and Its Receptors 1 and 2: Yin and Yang in Myocardial Infarction?
Circulation, March 17, 2009; 119(10): 1355 - 1357.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. N. Duran
The double-edge sword of TNF-{alpha} in ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2221 - H2222.
[Full Text] [PDF]


Home page
CirculationHome page
M. Wang, P. R. Crisostomo, T. A. Markel, Y. Wang, and D. R. Meldrum
Mechanisms of Sex Differences in TNFR2-Mediated Cardioprotection
Circulation, September 30, 2008; 118(14_suppl_1): S38 - S45.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
A. Ramachandran, S. Jha, and D. J. Lefer
REVIEW Paper: Pathophysiology of Myocardial Reperfusion Injury: The Role of Genetically Engineered Mouse Models
Vet. Pathol., September 1, 2008; 45(5): 698 - 706.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Galinanes, M. James, V. Codd, A. Baxi, and L. Hadjinikolaou
TNF-alpha gene promoter polymorphism at nucleotide -308 and the inflammatory response and oxidative stress induced by cardiac surgery: role of heart failure and medical treatment.
Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Reifenberg, H.-A. Lehr, M. Torzewski, G. Steige, E. Wiese, I. Kupper, C. Becker, S. Ott, P. Nusser, K.-I. Yamamura, et al.
Interferon-{gamma} Induces Chronic Active Myocarditis and Cardiomyopathy in Transgenic Mice
Am. J. Pathol., August 1, 2007; 171(2): 463 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Wang, T. Markel, P. Crisostomo, C. Herring, K. K. Meldrum, K. D. Lillemoe, and D. R. Meldrum
Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1694 - H1699.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz, and G. Heusch
Bidirectional Role of Tumor Necrosis Factor-{alpha} in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction
Circ. Res., January 5, 2007; 100(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Wang, B. M. Tsai, P. R. Crisostomo, and D. R. Meldrum
Tumor Necrosis Factor Receptor 1 Signaling Resistance in the Female Myocardium During Ischemia
Circulation, July 4, 2006; 114(1_suppl): I-282 - I-289.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
Y. Yano, R. Ozono, Y. Oishi, M. Kambe, M. Yoshizumi, T. Ishida, S. Omura, T. Oshima, and K. Igarashi
Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia/reperfusion in mice.
Genes Cells, July 1, 2006; 11(7): 791 - 803.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Maekawa, J.-i. Abe, T. Shishido, S. Itoh, B. Ding, V. K. Sharma, S.-S. Sheu, B. C. Blaxall, and B. C. Berk
Inhibiting p90 Ribosomal S6 Kinase Prevents Na+-H+ Exchanger-Mediated Cardiac Ischemia-Reperfusion Injury
Circulation, May 30, 2006; 113(21): 2516 - 2523.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. A. Moolman
Unravelling the cardioprotective mechanism of action of estrogens
Cardiovasc Res, March 1, 2006; 69(4): 777 - 780.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Brown, M. McGuinness, T. Wright, X. Ren, Y. Wang, G. P. Boivin, H. Hahn, A. M. Feldman, and W. K. Jones
Cardiac-specific blockade of NF-{kappa}B in cardiac pathophysiology: differences between acute and chronic stimuli in vivo
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H466 - H476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ramani, M. Mathier, P. Wang, G. Gibson, S. Togel, J. Dawson, A. Bauer, S. Alber, S. C. Watkins, C. F. McTiernan, et al.
Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1369 - H1377.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C.-Y. Xiao, K.-i. Yuhki, A. Hara, T. Fujino, S. Kuriyama, T. Yamada, K. Takayama, O. Takahata, H. Karibe, T. Taniguchi, et al.
Prostaglandin E2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP4
Circulation, May 25, 2004; 109(20): 2462 - 2468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chandrasekar, K. Vemula, R. M. Surabhi, M. Li-Weber, L. B. Owen-Schaub, L. E. Jensen, and S. Mummidi
Activation of Intrinsic and Extrinsic Proapoptotic Signaling Pathways in Interleukin-18-mediated Human Cardiac Endothelial Cell Death
J. Biol. Chem., May 7, 2004; 279(19): 20221 - 20233.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Eefting, B. Rensing, J. Wigman, W. J. Pannekoek, W. M. Liu, M. J. Cramer, D. J Lips, and P. A Doevendans
Role of apoptosis in reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 414 - 426.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Paz, I. Frolkis, D. Pevni, I. Shapira, Y. Yuhas, A. Iaina, Y. Wollman, T. Chernichovski, N. Nesher, C. Locker, et al.
Effect of tumor necrosis Factor-Alphaon endothelial and inducible nitric oxidesynthase messenger ribonucleic acidexpression and nitric oxide synthesisin ischemic and nonischemic isolated rat heart
J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1299 - 1305.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Belosjorow, I. Bolle, A. Duschin, G. Heusch, and R. Schulz
TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H927 - H930.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement